Courtney DG, Atkinson SD, Allen EH, Moore JE, Walsh CP, Pedrioli DM, MacEwen CJ, Pellegrini G, Maurizi E, Serafini C, Fantacci M, Liao H, Irvine AD, McLean WH, Moore CB. siRNA silencing of the mutant keratin 12 allele in corneal limbal epithelial cells grown from patients with Meesmann’s epithelial corneal dystrophy. Invest Ophthalmol Vis Sci. 2014 May 6;55(5):3352-60. PublicationsBy yan.taylor@cathedraleye.com07/02/2025
Atkinson SD, McGilligan VE, Moore JE, Tallouzi M, Feeney S, Sharma A, Shah S, Jackson J, Frazer DG, Moore TC. A Comparison Of The Clinical And Molecular Diagnosis Of Herpes Simplex Keratitis. Investigative Ophthalmology & Visual Science. 2011 Apr 22;52(14):6630 PublicationsBy yan.taylor@cathedraleye.com07/02/2025
de Wit DW, Diaz J, Moore TC, Moutari S, Moore JE. Effect of position of near addition in an asymmetric refractive multifocal intraocular lens on quality of vision. Journal of Cataract & Refractive Surgery. 2015 May 1;41(5):945-55. PublicationsBy yan.taylor@cathedraleye.com07/02/2025
Courtney DG, Toftgaard Poulsen E, Kennedy S, Moore JE, Atkinson SD, Maurizi E, Nesbit MA, Moore CB, Enghild JJ. Protein Composition of TGFBI-R124C- and TGFBI-R555W- Associated Aggregates Suggests Multiple Mechanisms Leading to Lattice and Granular Corneal Dystrophy. Invest Ophthalmol Vis Sci. 2015 Jul 1;56(8):4653-61 PublicationsBy yan.taylor@cathedraleye.com07/02/2025
Richoz O, Moore J, Hafezi F, Moore T. Corneal cross-linking as an adjuvant therapy in the management of recalcitrant deep stromal fungal keratitis: a randomized trial. American Journal of Ophthalmology. 2015 Sep 1;160(3):616-7. PublicationsBy yan.taylor@cathedraleye.com07/02/2025
Hamada S, Moore TC, Moore JE, Al-Dreihi MG, Anbari A, Shah S. Assessment of the effect of cyclosporine-A 0.05% emulsion on the ocular surface and corneal sensation following cataract surgery. Contact Lens and Anterior Eye. 2016 Feb 1;39(1):15-9. PublicationsBy yan.taylor@cathedraleye.com07/02/2025
Courtney DG, Thakur A, Nesbit MA, Moore JE, CB TM. A Review of Personalised Molecular Medicine for the Treatment of Corneal Disorders. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY & EYE SCIENCE. 2015 Aug 27;27:7-18. PublicationsBy yan.taylor@cathedraleye.com07/02/2025
Cathedral Eye Clinic Achieves 100% in RQIA Inspection Reports, UncategorizedBy Emily Harrop07/02/2025
Courtney DG, Moore JE, Atkinson SD, Maurizi E, Allen EH, Pedrioli DM, McLean WH, Nesbit MA, Moore CB. CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting. Gene therapy. 2016 Jan;23(1):108-12. PublicationsBy yan.taylor@cathedraleye.com07/02/2025
Moore T, Courtney D, Atkinson S, Maurizi E, Allen E, McLean I, Leslie Pedrioli D, Moore J, Nesbit A. Genetic modification possibilities in treating corneal diseases. Acta Ophthalmologica. 2015 Oct;93. PublicationsBy yan.taylor@cathedraleye.com07/02/2025